Cargando…

Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis

PURPOSE: To report the clinical outcomes of adalimumab in treating refractory Behcet’s disease (BD)-related uveitis in paediatric or adolescent patients. METHODS: Retrospective review of five paediatric or adolescent patients with BD-related uveitis with a minimum follow-up of 24 months. RESULTS: Di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Mary, Chen, Li Jia, Sin, Helena P. Y., Iu, Lawrence P. L., Brelen, Marten, Ho, Assunta C. H., Lai, Timothy Y. Y., Young, Alvin L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669227/ https://www.ncbi.nlm.nih.gov/pubmed/31367810 http://dx.doi.org/10.1186/s12348-019-0181-z

Ejemplares similares

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

4. A challenging case of refractory BehÇet's disease in an adolescent with sight threatening uveitis
por: Cooper, Gisella, et al.
Publicado: (2018)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
por: Al-Julandani, DA, et al.
Publicado: (2023)

Low-dose cyclosporine treatment for sight-threatening uveitis: Efficacy, toxicity, and tolerance
por: Mathews, D, et al.
Publicado: (2010)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
por: Tang Lee Say, Timothy Lee, et al.
Publicado: (2021)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

Fundus Autofluorescence and Optical Coherence Tomography Characteristics in Different Stages of Central Serous Chorioretinopathy
por: Ho, Mary, et al.
Publicado: (2021)

Clinical benefits and potential risks of adalimumab in non‐JIA chronic paediatric uveitis
por: Kouwenberg, Carlyn V., et al.
Publicado: (2021)

Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

Rise in intraocular pressure with elevator travel in post-vitrectomy patients
por: Wong, Posey P. Y., et al.
Publicado: (2023)

Pulmonary Sarcoidosis in Behçet’s Disease Treated with Adalimumab
por: Louro, Marlene, et al.
Publicado: (2017)

Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT
por: Gilbert, Rose M., et al.
Publicado: (2018)

Macular involvement in patients with Behçet’s uveitis
por: Kahloun, Rim, et al.
Publicado: (2012)

Vitreomacular Interface Disorders in Behçet’s Uveitis
por: Eser Öztürk, Hilal, et al.
Publicado: (2017)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report
por: Marsili, Manuela, et al.
Publicado: (2016)

Profile of adalimumab and its potential in the treatment of uveitis
por: Balevic, Stephen J, et al.
Publicado: (2016)

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)

An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma
por: Ghanchi, Faruque, et al.
Publicado: (2022)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

Early management of sight threatening retinopathy in incontinentia pigmenti
por: Michel, Sarah, et al.
Publicado: (2020)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Gender Differences in Behçet's Disease Associated Uveitis
por: Ucar-Comlekoglu, Didar, et al.
Publicado: (2014)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
por: Çakar Özdal, Pınar
Publicado: (2020)

Behçet uveitis: Current practice and future perspectives
por: Aboul Naga, Shereen H., et al.
Publicado: (2022)

How challenging can it be to treat Behçet uveitis?
por: Oray, Merih, et al.
Publicado: (2022)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Understanding and managing sight-threatening diabetic retinopathy
por: Yorston, David
Publicado: (2023)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2021)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease
por: Kaji, Mariko, et al.
Publicado: (2015)

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis
por: Yang, Shizhao, et al.
Publicado: (2021)

Associations between vitamin D status and sight threatening and non-sight threatening diabetic retinopathy: a systematic review and meta-analysis
por: Trott, Mike, et al.
Publicado: (2022)

Uveitis and Gender: The Course of Uveitis in Pregnancy
por: Chiam, Nathalie P. Y., et al.
Publicado: (2014)

Case series: rituximab in the treatment of refractory sight-threatening scleritis
por: van Bilsen, Kiki, et al.
Publicado: (2011)

Intraocular inflammation following COVID-19 vaccination: the clinical presentations
por: Li, Sophia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_la4emdc0120jdt625ttdhbtgt3